Paper
Loss of heterozygosity of tumour suppressor gene loci in human colorectal carcinoma

https://doi.org/10.1016/0959-8049(94)90541-XGet rights and content

Abstract

We used Southern blot analysis and polymerase chain reaction-based techniques to examine deletions of tumour suppressor gene loci in 91 primary colorectal tumours. The tumour suppressor genes studied were MCC and APC on chromosome 5q, p53 on chromosome 17p, DCC on chromosome 18q, and the putative suppressor gene nm23-H1 on chromosome 17q. The most frequent allelic loss observed was in chromosome 17p with 76% (6889) of informative tumours showing loss of heterozygosity at this locus, followed by 34% (1955) for DCC, 31% (1239) for MCC, 17% (953) for APC and 16% (319) for nm23. No significant differences in the frequency of these suppressor gene allelic losses were observed between Dukes B and C stage adenocarcinomas.

References (32)

  • SE Kern et al.

    Allelic loss in colorectal carcinoma

    JAMA

    (1989)
  • MJ O'Connell et al.

    Current status of adjuvant chemotherapy for colorectal cancer: can molecular markers play a role in predicting prognosis?

    Cancer

    (1992)
  • A Leone et al.

    Somatic allelic deletion of nm23 in human cancer

    Cancer Res

    (1991)
  • CE Dukes

    The classification of cancer of the rectum

    J Path Bact

    (1932)
  • Y Nakamura et al.

    Isolation and mapping of a polymorphic DNA sequence (pYNZ22) on chromosome 17p

    Nucleic Acids Res

    (1988)
  • S Kondoleon et al.

    A hypervariable RFLP on chromosome 17p13 is defined by an arbitrary single copy probe p144D6

    Nucleic Acids Res

    (1987)
  • Cited by (0)

    View full text